BEN-MAIMON CAROLE bought LRMR
November 11, 2026 · Form 4 insider transaction
BEN-MAIMON CAROLE bought 18,050 shares of Larimar Therapeutics, Inc. at $2.77 per share, a transaction worth $50.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.; The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.765 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.